| MAPK | mitogen activated protein kinases |
| CNS | central nervous system |
| LTP | long-term potentiation |
| LTD | long-term depression |
| AD | Alzheimer’s disease |
| ERK | extracellular signal-regulated kinases |
| EPSPs | synaptically evoked excitatory postsynaptic potentials |
| JNK | c-Jun amino-terminal kinases |
| ATP | adenosine triphosphate |
| NFAT | nuclear factor of activated T cells |
| ATF | activating transcription factor |
| STAT1 | signal transducer and activator of transcription |
| LPS | lipopolysaccharide |
| IL-1β | interleukin-1β |
| TNFα | tumor necrosis factor |
| AGEs | advanced glycation endproducts |
| mGluRs | metabotropic glutamate receptors |
| TFs | transcription factors |
| FMRP | fragile X mental retardation protein |
| Arc | activity-regulated cytoskeleton |
| BDNF | brain-derived neurotrophic factor |
| PSD95 | postsynaptic density protein 95 |
| RAGE | advanced glycation endproducts receptor |
| MCP-1 | monocyte chemoattractant proten-1 |
| iNOS | inducible nitric oxide synthase |
| NMDA | n-methyl-d-aspartate |
| LFS | low-frequency stimulation |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| Aβ | amyloid-β |
| EC | entorhinal cortex |
| Tg | transgenic |
| APP | amyloid precursor protein |
| PS1 | mutant human presenilin 1 |
| EP | endophilin |
| NF-KB | nuclear factor-kB |
| ROS | reactive oxygen species |
| MS | multiple sclerosis |
| PD | Parkinson’s disease |
| HD | Huntington’s disease |
| ALS | amyotrophic lateral sclerosis |
| KI | knock in |
| KO | knock out |
| S/T | serine-threonine |
| FPCR | G protein-coupled receptor |